Featured Research

from universities, journals, and other organizations

UCSD Bioengineers Discover Possible Cause And Treatment For Life-Threatening Shock

Date:
February 17, 2000
Source:
University Of California, San Diego -- Jacobs School Of Engineering
Summary:
Researchers prevented shock and multiple organ failure in experimental animals by blocking powerful pancreatic digestive enzymes in the intestine, according to studies by bioengineers with the Jacobs School of Engineering at the University of California, San Diego. This fundamental breakthrough could lead to therapies to prevent and treat ischemic shock in people who experience shock following blood loss from traumatic injury or high-risk surgery.

Researchers prevented shock and multiple organ failure in experimental animals by blocking powerful pancreatic digestive enzymes in the intestine, according to studies by bioengineers with the Jacobs School of Engineering at the University of California, San Diego. This fundamental breakthrough could lead to therapies to prevent and treat ischemic shock in people who experience shock following blood loss from traumatic injury or high-risk surgery. The work also provides clues into the cellular mechanisms that lead to shock.

The research report titled “Generation of In Vivo Activating Factors in the Ischemic Intestine by Pancreatic Enzymes” will be published in the Proceedings of the National Academy of Sciences on February 15. The principal investigator of the study is Geert Schmid-Schoenbein, professor of bioengineering at the Jacobs School of Engineering, and the work was funded by the National Heart, Lung, and Blood Institute. The research was conducted with Hiroshi Mitsuoka and Erik Kistler in Schmid-Schoenbein’s Microcirculation Research Laboratory.

Ischemic shock occurs when blood pressure falls after blood loss or deep anesthesia. Vital organs are poorly perfused and literally starved of oxygen. Early symptoms include cold, clammy skin, mental confusion and inadequate production of urine. But shock can quickly lead to multiple organ failure and even death.

These symptoms are induced when activators in the blood stream turn on various cardiovascular cells including leukocytes (white blood cells) and endothelial cells (blood vessel walls). Abnormal interactions between leukocytes and endothelial cells produce inflammation, alter blood flow, and finally cut off delivery of oxygen to the organs.

But never before have researchers found strong evidence for the source of the cell activators.

“The pancreas produces potent enzymes that can digest any tissue—even our own. These enzymes are regularly released into the intestines to digest our food,” said Schmid-Schoenbein. “Our theory is that when blood pressure falls sharply in the intestine, pancreatic enzymes in the intestine start to escape from the lumen of the intestine (where they digest food), into the wall of the intestine (where they don’t belong). These enzymes produce and release dangerous activators into the blood stream, initiating a cascade of events leading to multiple organ failure.”

To test their theory, the researchers surgically produced shock in rats. Control rats were given no treatment. But the researchers injected a broadly acting pancreatic enzyme inhibitor* into the lumen of the small intestine of the subject rats prior to inducing shock in the animals. The control rats experienced classic symptoms of shock including a drop in blood pressure, inflammation and multiple organ failure. The treated rats experienced much less pressure reduction, no activation of leukocytes or endothelial cells, no appearance of cell activators in the circulation, no inflammation, and no significant organ injury.

“We have clearly found a key source of the activators that lead to shock. This is a completely new result,” said Schmid-Schoenbein. “With this knowledge, we can begin to explore effective treatments with the possibility of preventing the death of thousands of people each year.”

Schmid-Schoenbein’s group is testing the procedure with different types of enzyme inhibitors. He is also taking initial steps to plan human trials.

*The inhibitor used was 6-amidino-2-naphtyl p-guanidinobenzoate dimethanesulfate,ANGD, 0.37 mM, also known as nafamostat mesilate or Futhan.


Story Source:

The above story is based on materials provided by University Of California, San Diego -- Jacobs School Of Engineering. Note: Materials may be edited for content and length.


Cite This Page:

University Of California, San Diego -- Jacobs School Of Engineering. "UCSD Bioengineers Discover Possible Cause And Treatment For Life-Threatening Shock." ScienceDaily. ScienceDaily, 17 February 2000. <www.sciencedaily.com/releases/2000/02/000217082926.htm>.
University Of California, San Diego -- Jacobs School Of Engineering. (2000, February 17). UCSD Bioengineers Discover Possible Cause And Treatment For Life-Threatening Shock. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2000/02/000217082926.htm
University Of California, San Diego -- Jacobs School Of Engineering. "UCSD Bioengineers Discover Possible Cause And Treatment For Life-Threatening Shock." ScienceDaily. www.sciencedaily.com/releases/2000/02/000217082926.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins